{ "cik": 1607678, "cik_padded": "0001607678", "entityName": "Viking Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001193125-26-046876", "filed": "2026-02-11", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 165810000.0, "eps_diluted": -3.19, "net_income": -359639000.0, "operating_cash_flow": -278685000.0, "operating_income": -393342000.0, "stockholders_equity": 639062000.0, "total_assets": 715729000.0, "total_liabilities": 76667000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.11996801562289731, "roa_avg2y": -0.4428915365906222, "roa_period_end": -0.502479290345927, "roe_avg2y": -0.47341477220372, "roe_period_end": -0.5627607337003295 } }, { "accn": "0001193125-26-046876", "filed": "2026-02-11", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 26676000.0, "eps_diluted": -1.01, "net_income": -109963000.0, "operating_cash_flow": -87790000.0, "operating_income": -150921000.0, "stockholders_equity": 880278000.0, "total_assets": 908321000.0, "total_liabilities": 28043000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.03185698154446663, "roa_avg2y": -0.1722463230658257, "roa_period_end": -0.12106182726150777, "roe_avg2y": -0.17899124031392605, "roe_period_end": -0.12491849165831702 } }, { "accn": "0001193125-26-046876", "filed": "2026-02-11", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 55516000.0, "eps_diluted": -0.91, "net_income": -85895000.0, "operating_cash_flow": -73376000.0, "operating_income": -100827000.0, "stockholders_equity": 348419000.0, "total_assets": 368490000.0, "total_liabilities": 20071000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.057605928494140674, "roa_avg2y": -0.3198955716650621, "roa_period_end": -0.23309994843822085, "roe_avg2y": -0.34793545603869236, "roe_period_end": -0.24652788739994091 } }, { "accn": "0000950170-25-027824", "filed": "2025-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 36632000.0, "eps_diluted": -0.9, "net_income": -68867000.0, "operating_cash_flow": -48397000.0, "operating_income": -70355000.0, "stockholders_equity": 145322000.0, "total_assets": 168529000.0, "total_liabilities": 23207000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.15969364583476695, "roa_avg2y": -0.3632311948332107, "roa_period_end": -0.40863590242628867, "roe_avg2y": -0.3966924534714262, "roe_period_end": -0.4738924595037228 } }, { "accn": "0000950170-24-012322", "filed": "2024-02-07", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 26371000.0, "eps_diluted": -0.71, "net_income": -54990000.0, "operating_cash_flow": -47586000.0, "operating_income": -55682000.0, "stockholders_equity": 201884000.0, "total_assets": 210662000.0, "total_liabilities": 8778000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.043480414495452833, "roa_avg2y": -0.23542053754142014, "roa_period_end": -0.2610342634172276, "roe_avg2y": -0.24646593221402513, "roe_period_end": -0.2723841413881239 } }, { "accn": "0001564590-22-004429", "filed": "2022-02-09", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 29117000.0, "net_income": -39495000.0, "operating_cash_flow": -21777000.0, "operating_income": -42662000.0, "stockholders_equity": 244344000.0, "total_assets": 256502000.0, "total_liabilities": 12158000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.04975771862619913, "roa_avg2y": -0.14607273493873416, "roa_period_end": -0.153975407599161, "roe_avg2y": -0.15147766955661285, "roe_period_end": -0.1616368726058344 } }, { "accn": "0001564590-21-006406", "filed": "2021-02-17", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 8377000.0, "net_income": -25779000.0, "operating_cash_flow": -24752000.0, "operating_income": -32687000.0, "stockholders_equity": 277119000.0, "total_assets": 284256000.0, "total_liabilities": 7137000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.02575427884771524, "roa_avg2y": -0.08789773734673559, "roa_period_end": -0.09068937858831476, "roe_avg2y": -0.08968651988539998, "roe_period_end": -0.09302501813300423 } }, { "accn": "0001564590-20-006766", "filed": "2020-02-26", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 24779000.0, "net_income": -22063000.0, "operating_cash_flow": -18755000.0, "operating_income": -26161000.0, "stockholders_equity": 297750000.0, "total_assets": 302312000.0, "total_liabilities": 4562000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.015321578505457598, "roa_avg2y": -0.13600959211917407, "roa_period_end": -0.07298089391092646, "roe_avg2y": -0.14178668054779026, "roe_period_end": -0.07409907640638119 } }, { "accn": "0001564590-19-007584", "filed": "2019-03-13", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 8988000.0, "net_income": -20578000.0, "operating_cash_flow": -14758000.0, "operating_income": -19070000.0, "stockholders_equity": 13464000.0, "total_assets": 22121000.0, "total_liabilities": 8657000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6429738562091504, "roa_avg2y": -1.1227413001734907, "roa_period_end": -0.9302472763437457, "roe_avg2y": -1.913621356378872, "roe_period_end": -1.5283719548425432 } }, { "accn": "0001564590-19-007584", "filed": "2019-03-13", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 3076000.0, "net_income": -14731822.0, "operating_income": -13847275.0, "stockholders_equity": 8042867.0, "total_assets": 14535708.0, "total_liabilities": 6492841.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8072794191424526, "roa_period_end": -1.0134918780701978, "roe_period_end": -1.8316630127043003 } } ], "latest_filing": { "accn": "0001193125-26-046876", "filed": "2026-02-11", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001607678.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001607678.json" }, "ticker": "VKTX" }